AVI BioPharma infectious, musculoskeletal news

AVI did not disclose the amount it expects to save from the restructuring,

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE